AR050574A1 - Uso de un compuesto para estimulacion del crecimiento de pelo - Google Patents
Uso de un compuesto para estimulacion del crecimiento de peloInfo
- Publication number
- AR050574A1 AR050574A1 ARP050100480A ARP050100480A AR050574A1 AR 050574 A1 AR050574 A1 AR 050574A1 AR P050100480 A ARP050100480 A AR P050100480A AR P050100480 A ARP050100480 A AR P050100480A AR 050574 A1 AR050574 A1 AR 050574A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- pharmaceutically acceptable
- alopecia
- hair growth
- stimulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se refiere a compuesto (3S,4R)-3,4-dihidro-4-(2,3-dihidro-2-metil-3-oxopiridazin-6-il)oxi-3-hidroxi-6-(3-hidroxifenil)sulfonil-2,2,3-trimietl-2H-benzo[b]pirano y su uso para promover el crecimiento de pelo y aliviar la alopecia. Reivindicacion 1: Uso de un compuesto de formula (1), una sal farmacéuticamente aceptable del mismo, o un solvato del mismo, en la fabricacion de un medicamento para alopecia. Reivindicacion 7: Una formulacion topica que comprende un compuesto de formula (1); una sal farmacéuticamente aceptable del mismo, o un solvato del mismo, en mezcla con al menos un vehículo topico farmacéuticamente aceptable. Reivindicacion 8: Un artículo de fabricacion que comprende una formulacion farmacéutica segun la reivindicacion 7 envasada para la distribucion al por menor, en asociacion con instrucciones que explican como usar dicha formulacion para tratar alopecia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54411604P | 2004-02-12 | 2004-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050574A1 true AR050574A1 (es) | 2006-11-08 |
Family
ID=34886004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050100480A AR050574A1 (es) | 2004-02-12 | 2005-02-10 | Uso de un compuesto para estimulacion del crecimiento de pelo |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20050182065A1 (es) |
| EP (1) | EP1715869A1 (es) |
| JP (1) | JP2007522201A (es) |
| KR (1) | KR100802848B1 (es) |
| CN (1) | CN1917878A (es) |
| AR (1) | AR050574A1 (es) |
| AU (1) | AU2005215258A1 (es) |
| BR (1) | BRPI0507669A (es) |
| CA (1) | CA2555741C (es) |
| IL (1) | IL177001A0 (es) |
| NO (1) | NO20064057L (es) |
| RU (1) | RU2006129320A (es) |
| TW (1) | TW200526222A (es) |
| WO (1) | WO2005079804A1 (es) |
| ZA (1) | ZA200606428B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6733714B2 (en) * | 2001-08-13 | 2004-05-11 | Edwin J. Oakey | Method for forming high-impact, transparent, distortion-free polymeric material |
| DK1562547T3 (da) * | 2002-11-12 | 2008-11-17 | Warner Lambert Co | Fremgangsmåde til at stimulere hårvækst under anvendelse af benzopyraner |
| KR100843862B1 (ko) * | 2004-07-16 | 2008-07-04 | 워너-램버트 캄파니 엘엘씨 | 모발 성장 촉진제 |
| BRPI0513401A (pt) * | 2004-07-19 | 2008-05-06 | Warner Lambert Co | formulação para estimular crescimento de cabelo |
| CN102791284A (zh) * | 2010-02-24 | 2012-11-21 | 艾德宛金国际私人有限公司 | 治疗或预防毛发脱落或促进毛发生长的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108841A0 (en) * | 1993-03-10 | 1994-06-24 | Pfizer Res & Dev | Benzopyrans |
| GB9316111D0 (en) * | 1993-08-04 | 1993-09-22 | Pfizer Ltd | Benzopyrans |
| US5547957A (en) * | 1993-10-15 | 1996-08-20 | Merck & Co., Inc. | Method of treating androgenic alopecia with 5-α reductase inhibitors |
| DK1562547T3 (da) * | 2002-11-12 | 2008-11-17 | Warner Lambert Co | Fremgangsmåde til at stimulere hårvækst under anvendelse af benzopyraner |
-
2005
- 2005-02-01 CN CNA2005800046470A patent/CN1917878A/zh active Pending
- 2005-02-01 JP JP2006552711A patent/JP2007522201A/ja not_active Withdrawn
- 2005-02-01 EP EP05702406A patent/EP1715869A1/en not_active Withdrawn
- 2005-02-01 AU AU2005215258A patent/AU2005215258A1/en not_active Abandoned
- 2005-02-01 KR KR1020067016169A patent/KR100802848B1/ko not_active IP Right Cessation
- 2005-02-01 RU RU2006129320/15A patent/RU2006129320A/ru unknown
- 2005-02-01 BR BRPI0507669-2A patent/BRPI0507669A/pt not_active IP Right Cessation
- 2005-02-01 CA CA2555741A patent/CA2555741C/en not_active Expired - Fee Related
- 2005-02-01 WO PCT/IB2005/000257 patent/WO2005079804A1/en active Application Filing
- 2005-02-04 TW TW094103636A patent/TW200526222A/zh unknown
- 2005-02-08 US US11/053,008 patent/US20050182065A1/en not_active Abandoned
- 2005-02-10 AR ARP050100480A patent/AR050574A1/es not_active Application Discontinuation
-
2006
- 2006-07-20 IL IL177001A patent/IL177001A0/en unknown
- 2006-08-02 ZA ZA200606428A patent/ZA200606428B/en unknown
- 2006-09-08 NO NO20064057A patent/NO20064057L/no not_active Application Discontinuation
-
2009
- 2009-02-10 US US12/368,329 patent/US20090143393A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007522201A (ja) | 2007-08-09 |
| RU2006129320A (ru) | 2008-02-27 |
| NO20064057L (no) | 2006-11-08 |
| CN1917878A (zh) | 2007-02-21 |
| KR20060114005A (ko) | 2006-11-03 |
| US20050182065A1 (en) | 2005-08-18 |
| CA2555741A1 (en) | 2005-09-01 |
| TW200526222A (en) | 2005-08-16 |
| ZA200606428B (en) | 2008-01-30 |
| EP1715869A1 (en) | 2006-11-02 |
| KR100802848B1 (ko) | 2008-02-12 |
| WO2005079804A1 (en) | 2005-09-01 |
| CA2555741C (en) | 2010-03-23 |
| BRPI0507669A (pt) | 2007-07-17 |
| IL177001A0 (en) | 2006-12-10 |
| WO2005079804A8 (en) | 2006-05-18 |
| AU2005215258A1 (en) | 2005-09-01 |
| US20090143393A1 (en) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| BRPI0506977A (pt) | composto de tetrahidrocarbolina como agentes anticáncer | |
| HN2004000232A (es) | " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden." | |
| CR10838A (es) | Derivados de 2,3-dihidroimidazol [1,2-c] quinazolina sustituidos, de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis | |
| BRPI0512237A (pt) | cis-imidazolinas | |
| UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
| TW200616650A (en) | Semi-solid delivery vehicle and pharmaceutical compositions | |
| UY29410A1 (es) | Composiciones farmacéuticas en base a metilamidas del ácido 4-(4-/-3(-4-cloro-3-trifluorometifenil)ureido)fenoxi)piridin-2-carboxílico, procedimiento de preparación y aplicaciones. | |
| UY27388A1 (es) | Nuevos compuestos | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| CL2007002228A1 (es) | Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composiicon empacada; metodos para esterelizarlas; util para cicatrizar tejido donde la dermis se ha desgarrado. | |
| MX9505182A (es) | Composicion terapeutica para aplicacion topica, que contiene un antagonista de la substancia p. | |
| SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
| BR0317524A (pt) | Compostos derivados de pirrolopirimidina, composição farmacêutica, processo para as suas preparações e respectivo uso | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| ECSP066878A (es) | [hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa | |
| WO2004052308A3 (en) | Topical anti-infective formulations | |
| ECSP055528A (es) | Composicion farmaceutica que tiene una distribución y potencia uniforme de farmaco | |
| BRPI0510684A (pt) | composições para adiministração tópica ou transdérmica de agente anticolinérgico ou antiespasmódico e uso dos respectivos compostos | |
| WO2005007072A3 (en) | Methods and pharmaceutical compositions for healing wounds | |
| MX2012007225A (es) | Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d. | |
| AR050574A1 (es) | Uso de un compuesto para estimulacion del crecimiento de pelo | |
| CA2505500A1 (en) | Method of stimulating hair growth using benzopyrans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |